Visum Technologies seeking admission to The AQSE Growth Market. The Company’s business is to own and operate an “on-ride” video and photographic camera system that it sells and/or licenses to customers (being theme parks, ride manufacturers, souvenir imaging providers, and other leisure operators). Due 30 June.
LifeSafe Holdings, a fire safety technology business with innovative fire safety products, intends to join AIM. LifeSafe has developed what the Directors believe to be market disrupting, eco-friendly fire safety protection products to both protect (via fire extinguishers) and detect (via carbon monoxide, smoke and heat alarms) fires. At the centre of the Group’s product range is the FER1000 extinguishing fluid, which has been developed by LifeSafe to extinguish five different types of fire: electrical, paper, textiles, cooking oil, and petrol and diesel. The Group’s best-selling product using this patent pending extinguishing fluid is the StaySafe 5-in-1 fire extinguisher. It was launched on Amazon Prime in the UK in August 2021 and subsequently became Amazon Prime’s top selling fire extinguisher in the UK in the same month. In n the year ended 31 December 2021, the Group generated revenues of £670k and a loss post taxation of £1.5m. £3m to be raised. Due early July 2022.
Altona Rare Earths, the AQSE listed mining exploration Company focused on the evaluation, acquisition and development of Rare Earth Elements mining projects in Africa, intends to join the Main Market. Admission to trading of the Company’s Ordinary Shares on the AQSE Growth Market will be cancelled simultaneously with Admission. It is also proposed that on Admission, the Company will change its EPIC from AQSE:ANR to REE. The Company also seeks to raise funds to finance its current and future rare earths mining projects in Southern and Eastern Africa. Due June 2022.
Braime Group 1,500p £22.6m (BMTO.L)
Further to its year end announcement, Braime now received a quotation for its chain cell project from the contractors for £1.6m, and anticipates additional surveying, legal, architectural and project management fees of £0.3m (a total of £1.9m). The cost of the project has increased from the estimate of £850k at the year-end. This is in part due to inflation on construction materials but a significant reason for the increase is the opportunity, to also more than double the area available for the production of 4B Chain, a growth area of the business, and create a new mezzanine area for additional storage and achieve other operating efficiencies. The plans to enhance the area, which are capital in nature, did not form part of the original repair costs of the external walls and account for £870k of the costs. Braime is in discussions with the bankers HSBC, and have secured their agreement in principle to borrow in the short term, £1.5m of development loan to fund the construction (with the balance being paid from existing cash resources) at an interest of 2.75% above base rate and expects to convert all or most of this to a five-year term loan when the construction is completed. The group is involved in the manufacture of metal presswork and the distribution of bulk material handling components.
Churchill China 1,415p £155.6m (CHH.L)
The manufacturer of innovative performance ceramic products serving hospitality markets worldwide, will hold its AGM at 12 noon today. At the meeting, Alan McWalter, Chairman, will make the following statement: “In our Preliminary Results, announced on 21 April 2022, we advised that we were experiencing record demand across our geographic markets. I am pleased to report that this demand has continued and our order book remains healthy. We remain confident in our ability to deliver an improved year on year performance in 2022. Last month we announced the retirement of Angela Bromfield from the Board, effective from the conclusion of the Annual General Meeting. I would like to re-iterate the Company’s thanks for her work over the last six years and wish her well for the future. As noted in our announcement of 19 May 2022, recruitment processes are underway to both identify a successor to Angela and also to reinforce independent representation on the Board.”
Empire Metals 1.3p £5.3m (EEE.L)
The resource exploration and development company, announced the commencement of the next campaign of reverse circulation drilling at the combined Eclipse-Gindalbie Gold Project in Western Australia. Commencement of an RC drilling campaign, consisting of over 3,290m of drilling across 26 drill holes, to target high grade mineralisation at combined Eclipse-Gindalbie Gold Project. The campaign will focus on the most prospective targets within the Eclipse-Gindalbie Project area, including Homeward Bound which has previously delivered very high-grade intercepts, including: 5m @ 8.99 g/t Au from 31m downhole, including 1m at 40.90 g/t Au, 3m @ 8.96 g/t Au from 98m downhole, including 2m at 13.28 g/t Au 3m @ 9.88 g/t Au from 46m downhole, including 1m at 26.20 g/t Au.
Intelligent Ultrasound 14.5p £39.2m (IUG.L)
The ‘classroom to clinic’ ultrasound company, specialising in artificial intelligence software and simulation, announces that at the AGM due to be held today at 11:00am at the offices of Memery Crystal, 165 Fleet Street, London EC4A 2DY, Non-Executive Chairman Riccardo Pigliucci will make the following statement: ” As noted at the publication of our full year results, we have had a strong start to 2022 and we continue to be confident in the upgraded market expectations for the full year 2022 revenue. We remain excited about the potential of our ‘Classroom to Clinic’ business.”
IQE 35.6p £286.2m (IQE.L)
The leading supplier of compound semiconductor wafer products and advanced material solutions to the global semiconductor industry, announced the signing of a multi-year agreement with Lumentum for the supply of epiwafers supporting 3D Sensing, LiDAR for automotive, and optical networking applications. Lumentum Holdings Inc., (NASDAQ: LITE) a market-leading photonics solutions provider, has been a long-term partner of IQE. Effective immediately, the multi-year agreement is focused on high volume production of epiwafers which will be used across Lumentum’s portfolio of innovative laser products, in particular to enable LiDAR for autonomous vehicles, where IQE will be the epitaxy partner of choice for this technology. The strong partnership between IQE and Lumentum will also enable leadership across a wider range of cutting-edge technologies such as biometric security, data communications, and extended reality. There is also further provision for multi-year joint research and development initiatives.
Jade Road Investments* 6.3p £7.2m (JADE.L)
The London quoted pan-Asian diversified investment vehicle, announced that the Company has successfully negotiated a partial divestment in Meize Energy Industries Holdings Limited, one of the leading privately-owned wind turbine blade manufacturing companies in China, currently the third-largest holding in the Company’s portfolio (7.7% of NAV as at announcement). On the 23rd of November 2011, the Company , through its wholly-owned subsidiary Swift Wealth Investments Limited, subscribed to USD7.5MM of Series B Preferred Shares. This investment equates to a shareholding of approximately 7.2% in Meize. The Company has entered into a share purchase agreement for 112,500 shares of the Series B Preferred Equity in Meize for consideration of USD1.2m. The Transaction Price will be received by the Company in three equal tranches. The number of shares sold in this partial divestment represents 12% of the Company’s holding in Meize. The Company will hold approximately 6.3% interest in Meize post this divestment. Before the release of this RNS, the Company received the First Tranche Price of USD400k. The Company expects to receive the Second and Third Tranche Price in late July and August 2022 as agreed in the SPA. The Transaction Price implies a valuation of USD10m for the Company’s investment in Meize, which indicates a 22% premium to the carrying value as at the 30th of June 2021 (USD8.2m). The profit from this disposal is USD0.3m. This divestment, of which the sale consideration is settled offshore, marks the culmination of a lengthy and successful turnaround effort by the Company for private investment in China.
Learning Technologies Group 113.9p £897.8m (LTG.L)
AGM Statement from the provider of services and technologies for digital learning and talent management. “As we stated in our full year results, our transformational GP Strategies’ acquisition continues to progress ahead of plan. The enlarged Group provides a platform to capture a greater proportion of the circa $100bn and growing addressable market in digital learning and talent management. While mindful of the current macro environment, strong business momentum has continued into the first half of 2022 and we have a robust balance sheet that will support further strategic acquisitions in due course, underpinning the Board’s confidence of significant progress. We are delighted by the progress made in the first half of this year and look forward to providing a Trading Update on 26 July”.
Trafalgar Property 0.3p £0.8m (TRAF.L)
The Residential property developer operating in southeast England, announces a trading update on its property interests: Trafalgar has exchanged contracts on a scheme in Speldhurst Kent that has planning permission granted for a large, detached property. It is the Company’s intention to reapply for planning on the site for a development of 1 and 2 Bedroomed apartments with off street parking. The Company’s development in Leatherhead Surrey for 8×2 Bedroomed apartments still remains in the planning system with a decision expected later this year. The Company retains certain properties for investment purposes, all of these properties are fully let with no void periods.
Skillcast 24p £21.5m (SKL.L)
Skillcast Group plc, the provider of content and technology for digital compliance transformation, announces that at the Company’s AGM being held today at 1pm at the Company’s registered office at 80 Leadenhall Street, London, EC3A 3DH, Richard Amos, Chairman, will provide the following update: “We are pleased to report continuing growth in our revenues and client base and continue to trade in line with expectations. Both subscription revenues from our SaaS products, which make up the majority of revenues, and ARR continue to grow on the prior year. Skillcast operates in the non-discretionary end of the corporate compliance and e-learning market and we remain confident that we are well placed to weather any future macro-economic challenges as we continue to help companies build ethical, inclusive and resilient workplaces. We look forward to providing a trading update on our half year performance in July 2022.”
Trident Royalties 44p £128.1m (TRR.L)
The diversified mining royalty and streaming company, released the below statement by its Non-Executive Chairman, Paul Smith, which will be read at today’s AGM. “2021 was a transformational year for Trident. We completed 4 investments during the year, followed by the acquisition of the gold offtake portfolio in January 2022. This brought the total number of assets to 22, of which 12 are now producing. The impact of these transactions was reflected in our Q1 results, which saw a 400% year on year increase in royalty receipts. Trident’s business model is well suited to the current economic environment as it provides investors with exposure to commodity prices but largely without the associated inflation in operating and capital costs. Appetite for mining development capital continues to be strong and royalties are likely to be an increasingly important component given more challenging public markets. We believe we are well placed to continue to create value for our shareholders and we look forward to providing updates over the course of the year.”
Disclaimer
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@chrish351.sg-host.com with “unsubscribe me”.
